Follow the people · Insider
Patrick A. Mayes
Patrick A. Mayes files insider transactions with the SEC as an evp & chief scientific officer of Incyte (INCY). We hold 3 disclosed purchases and sales filed since 3 October 2025, 3 of them in the last 90 days.
- Files forINCY
- Disclosed buys and sells3 in all, 3 in the last 90 days
- Last disclosure7 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 October 2025 — 5 August 2026EVP & Chief Scientific Officer · Incyte (INCY)58 Form 4 lines · source: SEC Form 4
Everything they disclosed
58 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 2,207 shares of IncyteSEC Form 47 August 2026Common Stock · traded 5 August 2026 · filed 7 August 2026
- ▼ sold on the open market 2,207 shares of IncyteSEC Form 47 August 2026Common Stock · traded 5 August 2026 · filed 7 August 2026
- exercised options over 2,207 shares of Incyte (a derivative holding)SEC Form 47 August 2026Employee Stock Option (right to buy) · traded 5 August 2026 · filed 7 August 2026
- exercised options over 2,918 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- exercised options over 3,023 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- exercised options over 2,623 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- exercised options over 1,642 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- exercised options over 2,293 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- exercised options over 85 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- exercised options over 326 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- ▼ sold on the open market 14,661 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- ▼ sold on the open market 5,332 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- ▼ sold on the open market 2,187 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- ▼ sold on the open market 6,171 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- exercised options over 2,284 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- ▼ sold on the open market 4,695 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- ▼ sold on the open market 2,864 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- ▼ sold on the open market 1,643 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- ▼ sold on the open market 1,642 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- ▼ sold on the open market 85 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- ▼ sold on the open market 326 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- ▼ sold on the open market 2,293 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- exercised options over 6,055 shares of IncyteSEC Form 44 August 2026Common Stock · traded 3 August 2026 · filed 4 August 2026
- ▼ sold on the open market 6,055 shares of IncyteSEC Form 44 August 2026Common Stock · traded 3 August 2026 · filed 4 August 2026
- exercised options over 2,918 shares of Incyte (a derivative holding)SEC Form 44 August 2026Employee Stock Option (right to buy) · traded 31 July 2026 · filed 4 August 2026
- exercised options over 2,709 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- exercised options over 2,284 shares of Incyte (a derivative holding)SEC Form 44 August 2026Employee Stock Option (right to buy) · traded 31 July 2026 · filed 4 August 2026
- exercised options over 2,709 shares of Incyte (a derivative holding)SEC Form 44 August 2026Employee Stock Option (right to buy) · traded 31 July 2026 · filed 4 August 2026
- exercised options over 3,148 shares of Incyte (a derivative holding)SEC Form 44 August 2026Employee Stock Option (right to buy) · traded 31 July 2026 · filed 4 August 2026
- exercised options over 2,072 shares of Incyte (a derivative holding)SEC Form 44 August 2026Employee Stock Option (right to buy) · traded 31 July 2026 · filed 4 August 2026
- exercised options over 9,459 shares of Incyte (a derivative holding)SEC Form 44 August 2026Employee Stock Option (right to buy) · traded 31 July 2026 · filed 4 August 2026
- exercised options over 2,623 shares of Incyte (a derivative holding)SEC Form 44 August 2026Employee Stock Option (right to buy) · traded 31 July 2026 · filed 4 August 2026
- exercised options over 2,864 shares of Incyte (a derivative holding)SEC Form 44 August 2026Employee Stock Option (right to buy) · traded 31 July 2026 · filed 4 August 2026
- exercised options over 1,643 shares of Incyte (a derivative holding)SEC Form 44 August 2026Employee Stock Option (right to buy) · traded 31 July 2026 · filed 4 August 2026
- exercised options over 3,023 shares of Incyte (a derivative holding)SEC Form 44 August 2026Employee Stock Option (right to buy) · traded 31 July 2026 · filed 4 August 2026
- exercised options over 2,623 shares of Incyte (a derivative holding)SEC Form 44 August 2026Employee Stock Option (right to buy) · traded 31 July 2026 · filed 4 August 2026
- exercised options over 3,148 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- exercised options over 1,642 shares of Incyte (a derivative holding)SEC Form 44 August 2026Employee Stock Option (right to buy) · traded 31 July 2026 · filed 4 August 2026
- exercised options over 2,293 shares of Incyte (a derivative holding)SEC Form 44 August 2026Employee Stock Option (right to buy) · traded 31 July 2026 · filed 4 August 2026
- exercised options over 85 shares of Incyte (a derivative holding)SEC Form 44 August 2026Employee Stock Option (right to buy) · traded 31 July 2026 · filed 4 August 2026
- exercised options over 326 shares of Incyte (a derivative holding)SEC Form 44 August 2026Employee Stock Option (right to buy) · traded 31 July 2026 · filed 4 August 2026
- exercised options over 6,055 shares of Incyte (a derivative holding)SEC Form 44 August 2026Employee Stock Option (right to buy) · traded 3 August 2026 · filed 4 August 2026
- exercised options over 2,072 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- exercised options over 9,459 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- exercised options over 2,623 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- exercised options over 2,864 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- exercised options over 1,643 shares of IncyteSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- was granted 5,916 shares of IncyteSEC Form 420 July 2026Common Stock · traded 16 July 2026 · filed 20 July 2026
- was granted 14,790 shares of Incyte (a derivative holding)SEC Form 420 July 2026Performance Shares · traded 16 July 2026 · filed 20 July 2026
- was granted 25,538 shares of Incyte (a derivative holding)SEC Form 420 July 2026Employee Stock Option (right to buy) · traded 16 July 2026 · filed 20 July 2026
- had shares withheld for tax on 437 shares of IncyteSEC Form 416 July 2026Common Stock · traded 14 July 2026 · filed 16 July 2026
- had shares withheld for tax on 1,512 shares of IncyteSEC Form 416 July 2026Common Stock · traded 15 July 2026 · filed 16 July 2026
- had shares withheld for tax on 350 shares of IncyteSEC Form 47 July 2026Common Stock · traded 2 July 2026 · filed 7 July 2026
- was granted 4,218 shares of Incyte (a derivative holding)SEC Form 421 January 2026Employee Stock Option (right to buy) · traded 16 January 2026 · filed 21 January 2026
- was granted 4,218 shares of Incyte (a derivative holding)SEC Form 421 January 2026Employee Stock Option (right to buy) · traded 16 January 2026 · filed 21 January 2026
- ▼ sold on the open market 5,553 shares of IncyteSEC Form 412 December 2025Common Stock · traded 10 December 2025 · filed 12 December 2025
- ▼ sold on the open market 255 shares of IncyteSEC Form 412 December 2025Common Stock · traded 11 December 2025 · filed 12 December 2025
- had shares withheld for tax on 1,569 shares of IncyteSEC Form 43 October 2025Common Stock · traded 1 October 2025 · filed 3 October 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.